In-hospital mortality after pancreatoduodenectomy reveals critical timing for interventions impacting patient outcomes. 3.5% of patients (156 of 4474) died in the hospital, primarily from three complication clusters: postpancreatectomy-specific (51.9%), vascular (25.6%), and cardiopulmonary (17.9%). Complications emerge at different postoperative intervals: median 9 days for postpancreatectomy, 4.5 days for vascular, and 3 days for cardiopulmonary issues. […]

Routine CA 19-9 surveillance detects recurrences early and enhances survival in resected ampullary cancer patients. Five-year overall survival stands at 56.4% in 572 patients, with 43.88% experiencing recurrences, predominantly distant. A serial rise in CA 19-9 is a strong predictor for recurrence, showing 71.05% sensitivity and 91.67% specificity. Detecting recurrences early through CA 19-9 testing […]

A standardized classification for postpancreatectomy mortality (PPM) can enhance surgical outcomes and patient safety. PPM defined as death within 90 days, attributable to surgical complications, offers clarity for reporting. Three categories identified: PPM 1 (15-30%, technical complications), PPM 2 (45-65%, mainly pancreatic fistulas), and PPM 3 (10-25%, cardiopulmonary issues). This new framework promises to guide […]

A new in situ anterior technique for dissecting the superior mesenteric artery (SMA) during laparoscopic pancreaticoduodenectomy improves outcomes. Operative time averaged 340 minutes with a blood loss of 200 ml. Patient had no complications, including pancreatic fistula, and was discharged on postoperative day 8. This technique minimizes tension on mesenteric vessels, reducing the risk of […]

Surgeons can safely perform robotic single-port right hepatectomy, offering a minimally invasive option for complex liver resections. The procedure took 241 minutes with minimal blood loss (100 ml) and no transfusions. The patient had negative resection margins and was discharged on postoperative day 7 without complications. This technique demonstrates feasibility and safety, suggesting it may […]

The T-MOD PD framework identifies preventable mortality opportunities after pancreatoduodenectomy, crucial for improving surgical outcomes. 57% of deaths linked to postoperative pancreatic fistula (POPF), with 38% occurring in an early, surgery-related, modifiable context. 74% of deaths classified as surgery-attributable potentially preventable. Surgeons can target interventions based on identified phenotypes to enhance patient safety and outcomes. […]

Robotic Whipple surgery shows promising outcomes, establishing benchmarks vital for surgical practice. Conversion rate ≤4.3%, transfusion rate ≤2.1%, and 6-month mortality ≤2.2%. Major complications capped at ≤23.2%, with clinically relevant pancreatic fistula and hemorrhage rates ≤23.6% and ≤12.7%, respectively. These benchmarks can guide patient selection and enhance surgical quality. Higher caseload centers reported fewer pancreas-specific […]

Surgeons should note that preoperative treatment duration over six months significantly improves survival outcomes for patients undergoing conversion surgery for unresectable locally advanced pancreatic cancer. Patients receiving >6 months of preoperative treatment showed median overall survival of 50.4 months versus 29.7 months for those with ≤6 months (p<0.001). Identifying four key prognostic factors can stratify […]

Post-pancreatectomy acute pancreatitis is crucial in predicting complications after pancreatoduodenectomy. 24.3% of patients developed clinically relevant postoperative pancreatic fistula (cr-popf); 90-day mortality was 3.4% overall, spiking to 9.0% with cr-popf. Post-pancreatectomy acute pancreatitis (ppap) was linked to a 4.88 times higher risk of 90-day mortality, making it a key independent predictor. Surgeons can enhance patient […]